WaferGen Financial Statements From 2010 to 2024
WaferGen Bio financial statements provide useful quarterly and yearly information to potential WaferGen Bio systems investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on WaferGen Bio financial statements helps investors assess WaferGen Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting WaferGen Bio's valuation are summarized below:WaferGen Bio systems does not presently have any fundamental gauges for analysis.
This module can also supplement various WaferGen Bio Technical models . Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Check WaferGen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WaferGen main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . WaferGen financial statements analysis is a perfect complement when working with WaferGen Bio Valuation or Volatility modules.
WaferGen |
WaferGen Bio systems Company Shares Owned By Insiders Analysis
WaferGen Bio's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current WaferGen Bio Shares Owned By Insiders | 19.50 % |
Most of WaferGen Bio's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WaferGen Bio systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 19.5% of WaferGen Bio systems are shares owned by insiders. This is much higher than that of the sector and significantly higher than that of the Shares Owned By Insiders industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
WaferGen Bio systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WaferGen Bio's current stock value. Our valuation model uses many indicators to compare WaferGen Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WaferGen Bio competition to find correlations between indicators driving WaferGen Bio's intrinsic value. More Info.WaferGen Bio systems is rated below average in return on asset category among related companies. It is rated below average in profit margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value WaferGen Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WaferGen Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WaferGen Bio's earnings, one of the primary drivers of an investment's value.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WaferGen Bio systems information on this page should be used as a complementary analysis to other WaferGen Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in WaferGen Stock
If you are still planning to invest in WaferGen Bio systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets |